Association of Cardiovascular Comorbidities on in-Hospital Outcomes of CAR T-Cell Therapy Recipients in the United States
Although there were significant differences in acute complications, our study reinforces that the presence of CVD does not adversely affect early mortality rates.
Authors
- Qi Xuan Ang (ORCID: https://orcid.org/0000-0002-3996-3811)
- Jon Arnason (ORCID: https://orcid.org/0000-0001-9038-7277)
- Arya Mariam Roy (ORCID: https://orcid.org/0000-0003-2509-312X)
- Nishi Shah (ORCID: https://orcid.org/0000-0002-4723-6745)
- Talal Hilal (ORCID: https://orcid.org/0000-0001-8249-4128)
- Jia Yi Tan (ORCID: https://orcid.org/0009-0002-7983-2928)
- Yong Hao Yeo (ORCID: https://orcid.org/0000-0001-5559-7236)
Institutions
- Albert Einstein College of Medicine (US)
- Sparrow Health System (US)
- Beth Israel Deaconess Medical Center (US)
- Montefiore Medical Center (US)
- New York Medical College (US)
- The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (US)
- WinnMed (US)
- Mayo Clinic in Florida (US)
- Saint Michael's Medical Center (US)
- Corewell Health
- Michigan State University (US)
Publication Details
- Journal
- Oncology
- Published
- 2025-08-27
- DOI
- https://doi.org/10.1159/000548191
- Primary Topic
- CAR-T cell therapy research
- Type
- article
- Field-Weighted Citation Impact
- 0.00